Cargando…
Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
Idiopathic pulmonary fibrosis (IPF) is a chronic, rare progressive lung disease, characterized by lung scarring and the irreversible loss of lung function. Two anti-fibrotic drugs, nintedanib and pirfenidone, have been demonstrated to slow down disease progression, although IPF mortality remains a c...
Autores principales: | Alonso-Gonzalez, Aitana, Tosco-Herrera, Eva, Molina-Molina, Maria, Flores, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172674/ https://www.ncbi.nlm.nih.gov/pubmed/37181377 http://dx.doi.org/10.3389/fmed.2023.1152211 |
Ejemplares similares
-
Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023) -
Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
por: Kaur, Amarpreet, et al.
Publicado: (2017) -
Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis
por: Moor, Catharina C., et al.
Publicado: (2017) -
Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018) -
Evolving cardiovascular genetic counseling needs in the era of precision medicine
por: Morales, Ana, et al.
Publicado: (2023)